NCT02706899 · Interventional trial
Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Myelodysplastic Syndrome
Delaware Valley sites
- University of Pennsylvania, Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory